Some of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Thursday. The funds bought over 415,000 shares altogether of Teladoc Health Inc. (NYSE: TDOC), as the prices of these ETFs bounced back on Thursday. Note that these funds are up handily in the past year.
[in-text-ad]
Here’s a look at the purchases:
- ARK Fintech Innovation ETF (NYSEARCA: ARKF) bought 40,224 shares.
- ARK Genomic Revolution ETF (NYSEARCA: ARKG) purchased 78,216 shares.
- ARK Innovation ETF (NYSEARCA: ARKK) added 234,681 shares.
- ARK Next Generation Internet ETF (NYSEARCA: ARKW) bought 62,024 shares.
At Thursday’s closing price, this would have valued these purchases at roughly $51.5 million. Even though this is a small fraction of the total holdings, every little bit counts. These funds are up more than 14% in the past 52 weeks, with the exception of the Genomic Revolution ETF, which is actually down 6%.
Check out all of the ARK Invest buys for Thursday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKF | KSPILI | KASPI.KZ | 11,813 |
ARKF | TDOC | TELADOC HEALTH | 40,224 |
ARKG | ALLO | ALLOGENE THERAPEUTICS | 214,497 |
ARKG | BNR | BURNING ROCK BIOTECH | 46,455 |
ARKG | TDOC | TELADOC HEALTH | 78,216 |
ARKK | TDOC | TELADOC HEALTH | 234,681 |
ARKK | SKLZ | SKILLZ | 257,636 |
ARKK | NTLA | INTELLIA THERAPEUTICS | 1,415 |
ARKK | MTLS | MATERIALISE | 26,915 |
ARKK | BEAM | BEAM THERAPEUTICS | 9,760 |
ARKQ | ACHR | ARCHER AVIATION | 184,473 |
ARKQ | BLDE | BLADE AIR MOBILITY | 227,784 |
ARKQ | VLD | VELO3D | 438,062 |
ARKW | SKLZ | SKILLZ | 494,859 |
ARKW | TDOC | TELADOC HEALTH | 62,024 |
ARKX | MKFG | MARKFORGED | 70,494 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.